Warning Health Canada has issued warnings on unauthorized peptide products. notices →
Registry Standards Violations About Submit a Source

Compound Report Registry Canada

Health Product Standards,
Reports & Ratings
Peptides, Nutraceuticals, and Natural Health Products.

Publicly testing records, government benchmarks, and violation data from regulators and health bodies worldwide. Purity scores are calculated against published standards. Searchable aggregated health product data for consumer safety.

Company Optional Search by vendor name
Registry populates on launch
Jurisdiction Optional Select country
🇨🇦 Canada
🇺🇸 United States
🇬🇧 United Kingdom
🇪🇺 European Union
🇦🇺 Australia
Category Optional All categories
ID Number Optional NPN · CBR · Lot · GTIN
Accepts: NPN · CBR number · Lot number · GTIN / UPC · FDA NDC
Keyword BPC-157, Berberine…
Search by compound name, ingredient, or product keyword
Try: BPC-157 Semaglutide NPN 80012345 CBR-524628 Berberine Canada

Registry

Recently Added Reports.

Aggregated from thousands of public and private testing sources. Free to access.

View Full Peptide Reports →
Operator Jurisdiction ICPS Status Reported Alert
Apex Biopharma
Third-party laboratory analysis identified significant discrepancies in stated purity levels.
 Canada High Risk Mar 15, 2026 Active
Nordic Peptide Group
Failed to provide third-party certificates of analysis on request. Under investigation by Health Canada.
 Canada Moderate Feb 28, 2026 Monitoring
PurePep Ltd.
Health Canada warning issued 2025 regarding products distributed without authorization.
 Canada High Risk May 14, 2025 Active
Syntek Research
Suspended by Health Canada. Enforcement action pursued for distribution of unapproved substances.
 Canada Critical Nov 10, 2024 Active
GlobalPep Inc.
Under ICPS review following third-party reports of COA misrepresentation.
 Canada High Risk Apr 10, 2026 Active
Operator Jurisdiction ICPS Status Reported Alert
VitaSource Canada
Product registration lapsed. Continued distribution under expired authorization.
 Canada Moderate Jan 20, 2026 Monitoring
Pure Essentials
Compliant with ICPS benchmarks. COA on file. Authorization in good standing.
 Canada Compliant Dec 5, 2025 Resolved
HealthWave Supplements
Label claims exceed documented purity levels. Flagged by independent testing source.
 Canada High Risk Mar 2, 2026 Active
Vitalix Inc.
Under ICPS review following third-party reports. Awaiting independent verification.
 Canada Under Review Apr 22, 2026 Monitoring
Operator Jurisdiction ICPS Status Reported Alert
BioSynth Canada
Distribution of unregistered research substances to non-licensed buyers. Cross-referenced with Health Canada records.
 Canada High Risk Feb 10, 2026 Active
ReGen Sciences
COA documentation under review. Purity claims pending independent verification.
 Canada Under Review Apr 1, 2026 Monitoring
Pinnacle Research
Minor labelling discrepancy identified. Operator notified. No active safety concern.
 Canada Moderate Nov 30, 2025 Monitoring

Registry populates as findings are aggregated and published. Submit a source →

Canada-Based · HPLC-Verified Results · Blockchain-Anchored · No Paid Placements · ICPS Standards · Independent Testing · Health Canada NHP Aligned

Why This Exists

The Compound Market Has
No Independent Testing Standard.

Vendors self-certify. COAs are issued by labs with commercial ties to the products they test. Buyers, regulators, and customs authorities have no reliable way to verify purity claims across vendors, and no independent platform aggregates and publishes verified findings by compound.

CompoundPurity addresses this gap by aggregating test data from thousands of public and private institutions worldwide, including government bodies, accredited labs, research institutions, and independent testing organizations. We assess every finding against applicable standards and publish without vendor input. We do not conduct testing. We report on it.

0
Canadian independent testing standards
for peptides and research compounds
0
No government body has established enforceable
purity thresholds for novel peptides in Canada
International Compound Purity Standards

The Process

Aggregated Data. Assessed Against Standards. Permanent Record.

Step 01

Aggregate

We collect test data from thousands of public and private sources worldwide, including government agencies, accredited laboratories, research institutions, and independent testing organizations. We do not conduct testing.

Step 02

Assess

Every finding is evaluated against applicable comparability standards, whether established by government regulation, recognized institutional bodies such as USP or ISO, or ICPS-published frameworks. No vendor has input on the assessment.

Step 03

Anchor

Verified findings are hashed and anchored permanently on the blockchain via CompoundLedger.org the moment they are published. No record can be altered after issuance.

Step 04

Publish

Findings are published to the public registry and indexed by compound, vendor, jurisdiction, and identification number. Every record is permanently searchable and freely accessible.

The Standard

No Paid Placements. No Vendor Input. No Exceptions.

Aggregated Reporting

Thousands of Sources

CompoundPurity aggregates test data from thousands of public and private institutions worldwide. We report on findings. We do not conduct testing. No vendor has input on what is published.

Blockchain-Anchored

Permanent Record

Every test result is hashed and written to a public blockchain the moment it is issued, via CompoundLedger.org. The record exists permanently. No one can alter it after issuance.

ICPS Standards

Governed by ICPS

CompoundPurity is operated by the International Compound Purity Standards, an independent, non-commercial standards body. Technology provided by BTHBiohealth.

Submit a testing source.
The record is permanent.

Submit a Source How It Works